Phase Ib/II Study of Polatuzumab Vedotin in Combination With Rituximab and Chidamide in Newly Diagnosed Elderly Patients With Double-Expressor DLBCL
Clinical trial NCT07415980 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07415980
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-04-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.